Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
| ▸ | NPC1 | O15118 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | AURKA | O14965 | 1/20 | 0.59 |
| ▸ | PIM1 | P11309 | 1/20 | 0.59 |
| ▸ | CDK2 | P24941 | 1/20 | 0.59 |
| ▸ | GSK3B | P49841 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6833454 | 0.98 | RAB9A (0.57) | RAB9AKMT2ASMN1; SMN2NPC1MEN1 | |
| Bromide SCHEMBL7502411 | 0.98 | RAB9A (0.57) | RAB9AKMT2ASMN1; SMN2NPC1MEN1 | |
| SCHEMBL27630368 | 0.89 | PLA2G7 (0.55) | RAB9AKMT2ASMN1; SMN2NPC1MEN1 | |
| SCHEMBL8906815 | 0.86 | PLA2G7 (0.59) | RAB9AKMT2ASMN1; SMN2NPC1MEN1 | |
| SCHEMBL10625612 | 0.84 | PLA2G7 (0.51) | RAB9AKMT2ASMN1; SMN2NPC1MEN1 | |
| SCHEMBL17397927 | 0.83 | PLA2G7 (0.49) | RAB9AKMT2ASMN1; SMN2NPC1MEN1 | |
| SCHEMBL9343718 | 0.82 | NPC1 (0.57) | RAB9AKMT2ASMN1; SMN2NPC1MEN1 | |
| SCHEMBL27923797 | 0.81 | MAPT (0.53) | RAB9AKMT2ASMN1; SMN2NPC1MEN1 | |
| SCHEMBL3048424 | 0.81 | SYK (0.60) | RAB9AKMT2ASMN1; SMN2NPC1MEN1 | |
| SCHEMBL11896454 | 0.81 | PLA2G7 (0.51) | RAB9AKMT2ASMN1; SMN2NPC1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115385868-A | Synthesis and application of ClbP fluorescent probe with high selectivity recognition | 湖南师范大学 | 2022-11-25 | — | — | CN | claimed |
| EP-1392309-B1 | SUBSTITUTED PYRAZINONES, PYRIDINES AND PYRIMIDINES AS CORTICOTROPIN RELEASING FACTOR LIGANDS | BRISTOL MYERS SQUIBB CO (US) | 2007-01-17 | — | — | EP | claimed |
| EP-0871619-B1 | PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES | BOEHRINGER INGELHEIM PHARMA (US) | 2002-11-06 | — | — | EP | claimed |
| US-6288091-B1 | COMPOUNDS SUCH AS 2,2,2-TRICHLOROETHYL N-(4-(2-AMINO-4-THIAZOLYL)-PHENYL)CARBAMATE THAT INHIBIT THE HERPES HELCASE-PRIMASE ENZYME COMPLEX | BOEHRINGER INGELHEIM LTD. (CA) | 2001-09-11 | — | — | US | claimed |
| EP-0871619-A1 | PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 1998-10-21 | — | — | EP | claimed |
| WO-1997024343-A1 | PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1997-07-10 | — | — | WO | claimed |
| JP-6056808-A | — | — | None | — | — | JP | disclosed |
| CN-120271526-B | Phenylaminothiazole derivative and application thereof as bactericide | 安徽理工大学 | 2025-10-31 | — | — | CN | disclosed |
| CN-120271526-B | Phenylaminothiazole derivative and application thereof as bactericide | 安徽理工大学 | 2025-10-31 | — | — | CN | disclosed |
| CN-120271526-A | Phenylaminothiazole derivative and application thereof as bactericide | 安徽理工大学 | 2025-07-08 | — | — | CN | disclosed |
| CN-120271526-A | Phenylaminothiazole derivative and application thereof as bactericide | 安徽理工大学 | 2025-07-08 | — | — | CN | disclosed |
| US-20250188072-A1 | COMPOUNDS FOR TREATMENT OF CANCER | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2025-06-12 | — | — | US | disclosed |
| US-12187720-B2 | Compounds for treatment of cancer | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2025-01-07 | — | — | US | disclosed |
| US-6057451-A | AMINOTHIAZOLE DERIVATIVES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0871619-A1 | PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 1998-10-21 | — | — | EP | disclosed |
| WO-1997024343-A1 | PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1997-07-10 | — | — | WO | disclosed |
| JP-H0656808-A | N-THIAZOLYLANILINE DERIVATIVE, ITS PRODUCTION AND PEST CONTROLLING AGENT | UBE IND LTD | 1994-03-01 | — | — | JP | disclosed |
| EP-0192998-B1 | THIAZOLYL AMIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN COMBATING NON-DESIRED PLANT GROWTH | BASF Aktiengesellschaft (DE) | 1990-01-24 | — | — | EP | disclosed |
| US-4769062-A | Thiazolylamides, their preparation, and their use for controlling undesirable plant growth | BASF AKTIENGESELLSCHAFT (DE) | 1988-09-06 | — | — | US | disclosed |
| EP-0192998-A2 | Thiazolyl amides, process for their preparation and their use in combating non-desired plant growth | BASF Aktiengesellschaft (DE) | 1986-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12187720-B2 | Compounds for treatment of cancer | KLK3, BRDT, ACP3 | RAB9A 1147/4885KMT2A 2242/4885SMN1; SMN2 3816/4885 |
| US-20250188072-A1 | COMPOUNDS FOR TREATMENT OF CANCER | KLK3, BRDT, ACP3 | RAB9A 1147/4885KMT2A 2242/4885SMN1; SMN2 3816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.